The invisible victims

Article Abstract:

Current surveys report that about 54 percent of kids suffering from malaria in Africa receive an anti-malarial drug, but fail to seize information on the effectiveness, timings, and dose of the treatment. The researchers are found responsible since they lack to evaluate the accurate impact of interventions such as drugs or insecticide-impregnated bed net.

Pharmaceutical Preparation Manufacturing, Antimalarial & Antifungal Preps, Dosage and administration, Child health, Malaria, Antimalarials

---

New vaccines enter fray in fight against tuberculosis

Article Abstract:

Clinical trials in Africa are testing new vaccines against tuberculosis. The available Bacillus Calmette-Guerin (BCG) vaccine is safe is used globally. According to the World Health Organization (WHO), about one-third of the world's population is infected with tuberculosis.

Product information, Testing, Clinical trials, Tuberculosis, Vaccines

---

The natural history of HIV-1 infection in Africa

Article Abstract:

HIV infection in African patients is widely thought to progress more rapidly than in patients from industrialized nations, and AIDS in Africa is often regarded as a separate disease from cases in northern countries. Research has proven these notions to be misconceptions.

Health aspects, Research, History, HIV infection, HIV infections, AIDS (Disease), AIDS research

Similar abstracts:

• Abstracts: The case for routine childhood vaccination against hepatitis A. Chronic hepatitis C virus infection
• Abstracts: The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
• Abstracts: West Nile virus--not a passing phenomenon. West Nile virus encephalitis in America. The outbreak of West Nile virus infection in the New York City area in 1999
• Abstracts: Learning to work with social workers. NVQ training unlocks the potential of nursing auxiliaries. Coaching for health care assistants
• Abstracts: Prevention of lyme disease after tick bites: a cost effectiveness analysis. Doxycycline for tick bites -- not for everyone

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.